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We have identified disruptions in the dedicator of cytokinesis 8 gene, DOCK8, in two unrelated patients with mental retardation (MR). In one
patient, a male with MR and no speech, we mapped a genomic deletion of approximately 230 kb in subtelomeric 9p. In the second patient, a
female with mental retardation and ectodermal dysplasia and a balanced translocation, t(X;9) (q13.1;p24), we mapped the 9p24 breakpoint to a
region overlapping with the centromeric end of the 230-kb subtelomeric deletion. We characterized the DOCK8 gene from the critical 9p deletion
region and determined that the longest isoform of the DOCK8 gene is truncated in both patients. Furthermore, the DOCK8 gene is expressed in
several human tissues, including adult and fetal brain. Recently, a role for DOCK8 in processes that affect the organization of filamentous actin
has been suggested. Several genes influencing the actin cytoskeleton have been implicated in human cognitive function and thus a possibility
exists that the rare mutations in the DOCK8 gene may contribute to some cases of autosomal dominant mental retardation.
© 2007 Elsevier Inc. All rights reserved.Keywords: Subtelomere; Mental retardation; Chromosome translocation; DOCK8; AutosomeMental retardation (MR) is the most common developmental
disability, affecting intellectual and adaptive functions in
approximately 1–3% of the population. Yet, the underlying
cause of MR is established in fewer than half the cases [1,2].
Genetic factors in MR likely include mutations in genes
distributed throughout the genome and are already well
established for the genes on the X chromosome [1,2]. The
finding of MR among almost all patients with autosomal
microdeletions and the association of MR with submicroscopic
alterations in the subtelomeric region of the autosomes further
indicate the ubiquitous distribution of autosomal genes that
influence intelligence [3–5].
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doi:10.1016/j.ygeno.2007.10.011developmental disabilities (MR/DD) [6]. About 5% of idio-
pathic MR can be explained by deletions or rearrangements of
the subtelomeric regions of the autosomes [5–9]. A large
number of subtelomeric deletions have been observed in
patients with MR, suggesting that these deletions are likely to
harbor a gene(s) responsible for the observed phenotypes in
these patients. Furthermore, analysis of patients with submi-
croscopic deletions has facilitated identification of small regions
of overlap linked to specific phenotypic characteristics and
subsequent isolation of the causative genes. Recently, disrup-
tion of the EHMT1 gene has been shown to be associated with
the 9q34 subtelomeric deletion syndrome [10,11].
Here we characterized, at the DNA level, chromosomal
rearrangements involving 9p24 in two unrelated patients with
mental retardation and developmental disabilities. We have
characterized theDOCK8 gene from the critical 9p subtelomeric
region, determined the expression of the DOCK8 gene in fetal
and adult human brains, and demonstrated that the longest
isoform of the gene is physically disrupted in both patients.
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Molecular analysis of the subtelomeric deletion in a patient
with mental retardation and developmental disability
Subtelomeric FISH analysis revealed deletion of a probe
from the 9p subtelomeric region (ish 9pter (305J7-T7 x1)) in
patient CMS6482 (Figs. 1a and b). This probe was found to
map within a genomic contig (NT_008413; NCBI) in 9p24.3
(Fig. 1a). We identified physically mapped genomic clones
from the contig and used them systematically in FISH analyses
to determine the extent of the subtelomeric 9p deletions in this
patient (Fig. 1a and Table 1). A part of the 9p subtelomeric
region has previously been shown to share sequence homology
with other regions of chromosome 9 [12]. Consistent with that
report, probes RP11-143M1 and RP11-174M15 gave three
FISH signals on a normal chromosome 9: one at the 9p sub-
telomere and two others in 9p12 and 9q21.2 regions. However,
the 9p subtelomere-specific FISH signal with clone RP11-Fig. 1. Mapping of the subtelomeric 9p chromosomal rearrangements. (a) An idiogram
the BAC clones used in FISH analysis, and known genes (in italics) are shown. Blac
critical deletion region (red bar) in patient CMS6482 and a region (blue bar) harborin
DOCK8 gene and a schematic of the 2031 amino acids DOCK8 variant are shown.
analyses in CMS6482. (b) Chromosome 9 subtelomeric probes (9p, green; 9q red) pro
subtelomeric deletion in CMS6482. Red signal was present on both the normal and the
normal chromosome 9 and not on the deleted chromosome 9 (arrow), indicating deletio
color. (d) Probe RP11-910H2 (green, arrowheads) is partially deleted on the deriv
chromosome 9. The chromosome 9 centromeric probe is in light red color. (e) FI
translocation breakpoint in CMS1485. The probe is present on the normal chromosome
is in light red color. (f) PFGE analysis with a probe located in the 3′ portion of DOCK
sample. (g) Fine mapping of the 9p critical region with quantitative genomic PCR in C
reveals that the 9p subtelomeric deletion in CMS6482 extends at least through exon 2
translocation located between exon 23 and exon 34 with exon 29 deleted. The value174M15 was absent in CMS6482, indicating a deletion of this
region in the patient (Supplementary Fig. 1 and Table 1). Probe
RP11-59O6 gave a signal on the normal chromosome 9 but not
on the deleted chromosome 9 (Fig. 1c). Probe RP11-910H2
gave signals on the normal chromosome 9, as well as a reduced
signal on the derivative chromosome 9, suggesting this probe is
partially deleted (Fig. 1d). All FISH probes gave expected
signals on the normal chromosome 9 in a control sample (not
shown). These results determined the deletion in patient
CMS6482 to be between genomic clones RP11-143M1
(telomeric) and RP11-910H2 (centromeric) (Fig. 1a).
Mapping of the 9p chromosomal breakpoint in a female patient
with MR, anhidrotic ectodermal dysplasia, and a de novo
t(X;9) (q13;p24) translocation
We previously mapped the Xq13 chromosome breakpoint
of patient CMS1485 within intron 1 of the anhidrotic ecto-
dermal dysplasia (EDA) gene (Xq13) and determined that theof chromosome 9 with a partial physical map of the subtelomeric 9p24.3 region,
k arrows indicate the direction of the transcription. FISH analyses determined a
g the 9p24 translocation breakpoint in CMS1495. The genomic structure of the
The predicted DOCK domain in the C-terminal region is indicated. (b–d) FISH
duced a green signal only on one chromosome 9 and not the other, indicating a 9p
deleted chromosomes 9. (c) RP11-59O6 (red) gave a signal (dark red) only on the
n of this probe in CMS6482. The chromosome 9 centromeric probe is in light red
ative chromosome 9 and gave signals on both the normal and the derivative
SH analysis in CMS1485. Probe RP11-910H2 (green) is distal to the 9p24.3
9 as well as the derivative X chromosome. The chromosome 9 centromeric probe
8 reveals an abnormally migrating fragment in CMS1485 but not in the control
MS6482, CMS1485, and three controls (CMS11195, CMS5865, and CMS6265)
3 of the DOCK8 gene. CMS1485 has a deletion presumably associated with the
s represent the average of three replicates used in each case.
Fig. 1 (continued ).
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to the disruption of the EDA gene [14,15]. Thus, the MR is
presumably associated with the 9p24 breakpoint. To refine the
9p24 chromosomal breakpoint, FISH analysis was performed,
using three clones spaced across chromosomal band 9p24. All
three clones initially used (RP11-130C19, RP11-125K10, and
RP11-376O21) mapped proximal to the 9p breakpoint and gave
signals on both the normal chromosome 9 and the derivative 9
(Table 1). FISH analysis with additional clones narrowed the
location of the 9p breakpoint between clones RP11-174M15
and RP11-165F24. Clones RP11-143M1 and RP11-174M15
mapped distal to the breakpoint (Fig. 1a and Table 1). Both
probes gave FISH signals on the normal chromosome 9, but
also gave a 9p-specific signal on the derivative X chromosome.
Clone RP11-165F24 mapped proximal to the breakpoint and
gave signals on both the normal and the derivative chromosome
9 (Table 1). Furthermore, clone RP11-59O6 also mapped distalto the breakpoint (Fig. 1a). Genomic clone RP11-910H2
partially overlaps both RP11-59O6 and RP11-165F24. FISH
analysis with RP11-910H2 revealed signals on the normal
chromosome 9 and the derivative X (Fig. 1e). These results
suggested the chromosome 9 translocation breakpoint lies
within the overlap of these two adjacent and partially
overlapping clones (RP11-59O6 and RP11-165F24) (Fig. 1a),
further narrowing the translocation breakpoint region (Fig. 1a),
and also suggested the possibility of a microdeletion at the
breakpoint.
Delineation of a putative critical MR region in subtelomeric 9p
and identification of DOCK8 as a candidate MR gene
Sequence information corresponding to the critical subtelo-
meric deletion region (Fig. 1a) was obtained from the NCBI
database. We further analyzed end sequences of BAC/PAC
Table 1
Chromosome 9p BAC/PAC FISH and subtelomeric analysis
FISH probe CMS6482 9p24 del CMS1485 t(X;9)
RP11-143M1 Normal Distal
RP11-174M15 Deleted Distal
Subtelomeric probe 305J7-T7 a Deleted NC
RP11-59O6 Deleted Distal






a Subtelomeric probe from Vysis, Inc.
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of the overlapping genomic clones. We deduced the minimal
critical deletion region to approximately 230 kb in CMS6482.
In silico analysis of the gene content of the 9p24 deleted
region and the flanking regions showed the presence of known
and putative genes (Fig. 1a). A known gene, FOXD4 (GenBank
Accession No. AY344640), is located near the telomeric end of
the deletion, and another gene, CBWD1, encoding a COBW-
like protein, was also found in a homologous region on human
chromosome 2p13 [12]. Two putative genes, LOC389701 and
FLJ00026, mapped near the proximal end of the 9p sub-
telomeric deletion region (not shown). EST alignments of
cDNAs and RT-PCR subsequently showed these two putative
genes to be partial sequences of a single gene, DOCK8 (Fig.
1a). We and others have characterized the DOCK8 gene in
detail [13,16]. The gene consists of 47 exons spanning
approximately 190 kb of genomic DNA (Fig. 1a).
These results suggested that the subtelomeric deletion in
patient CMS6482 disrupts the DOCK8 gene. Furthermore, the
results demonstrated that the 9p24 translocation breakpoint in
CMS1485 lies within the DOCK8 gene (Fig. 1a). To support the
findings in CMS1485 further, pulsed-field gel electrophoresis
(PFGE) analysis was performed. A DOCK8 cDNA probe
detected a normal fragment of approximately 190 kb and a
novel fragment of approximately 250 kb in the patient's DNA
digested with SalI (Fig. 1f ), indicating a likely disruption of the
DOCK8 gene in this patient.Fig. 2. Tissue expression profile of human DOCK8 variants. (a) Schematic diagram
expressed in all fetal tissues tested. Variant 2 expression could be detected only in fWe used quantitative genomic PCR to narrow further the
centromeric boundary of the 9p subtelomeric deletion in patient
CMS6482 and the putative microdeletion at the 9p breakpoint in
CMS1485. We analyzed five amplicons of the DOCK8 gene
and identified a deletion of one copy of three amplicons
representing intron 13, exon 18, and exon 23 in CMS6482 and
determined the centromeric boundary of the subtelomeric
deletion to lie within the gene DOCK8 (Figs. 1a and g) in
CMS6482. The deletion in this patient extends through nearly
half of the 5′ end of DOCK8. In CMS1485, quantitative
genomic PCR revealed a microdeletion of up to 37 kb located
between exons 23 and 34 of DOCK8 (Fig. 1g) and mapped the
microdeletion in this patient to a region overlapping with the
centromeric end of the 230-kb subtelomeric deletion observed
in CMS6482 (Fig. 1a).
Characterization of DOCK8 and its expression studies
The longest DOCK8 transcript of approximate 8 kb encodes
a protein of 2031 aa that contains a DOCK domain in the C-
terminal region (Fig. 1a). The NCBI database analysis revealed
multiple splice variants of the DOCK8 gene. Two DOCK8
variants lacked residues 859–890 or residues 959–972. In
addition, one variant had an additional 68 aa residues at its N-
terminal [16]. Analysis of the available EST sequences further
revealed two smaller variants of the gene (Fig. 2a). Northern
analysis of fetal and adult human tissue using the DOCK8
cDNA as a hybridization probe detected a transcript of about
8.0 kb in all human tissues analyzed. To monitor DOCK8 gene
expression in the human brain, we used Northern blots
containing RNAs from different regions of the adult human
brain. A variable level of expression was detected in all brain
regions (Supplementary Fig. 2). Expression analysis in a panel
of fetal cDNAs also revealed the presence ofDOCK8 transcripts
in most tissues, including fetal brain (Fig. 2b).
We used RT-PCR to investigate the tissue distribution of the
three splice variants (Figs. 2a and b). All three variants of
DOCK8 were expressed at variable levels in all tissues analyzed
(Fig. 2b). No expression or a comparatively low level of ex-
pression was noted for variant 2 in brain, heart, and skeletal
muscle (Fig. 2b, middle).of primer locations used in variant specific RT-PCR. (b) Variants 1 and 3 are
etal lung, liver, kidney, spleen, and thymus.
Fig. 3. Actin structure of fibroblast cell lines CMS11195 (control) and CMS1485 (patient). Filamentous actin was detected by Alexa Fluor 488 phalloidin green and the
cells were examined by immunofluorescence microscopy. The nucleus is visualized using Sytox orange.
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Using incorporation PCR SSCP (IPS) or denaturing high-
performance liquid chromatography (DHPLC) (see Material
and methods for details), we screened all 47 exons of the
DOCK8 gene for alterations in a cohort of 145 patients with
MR. Five single-nucleotide variations were identified (Supple-
mentary Table 1), including two previously known variants,
p.P1876P and p.A1902V. Two intronic variations (IVS4+
14A→G and IVS4+65G→A) were too frequent in the MR
cohort and were considered likely to be polymorphisms rather
than MR-causing mutations. One missense alteration, p.
L1262V, which appeared to be unique in the MR cohort
(frequency 0.68%), was subsequently identified in controls
(frequency 1.25%). Additionally, we also identified an
alteration, p.S97L, in a random control individual (Supplemen-
tary Table 1).
Analysis of actin organization in CMS1485 fibroblast cell lines
In an attempt to examine a likely involvement of DOCK8 in
the organization of filamentous actin, we performed immuno-
fluorescence microscopy with the actin stain phalloidin on the
X;9 translocation cell line (CMS1485) and a control fibroblast
cell line. No measurable difference in actin organization or cell
size was observed between the control and the patient cells
(Fig. 3).
Discussion
An important cause of MR has been shown to be
chromosomal abnormalities that result in segmental aneuploidy.
MR/DD-associated subtelomeric deletions in patients provide
critical genomic intervals for the identification of the causative
genes that yield the various associated clinical features. Here we
have defined the 9p subtelomeric region associated with MR/
DD in two unrelated patients. The MR-associated critical region
defined here mapped further telomeric to the previously defined9p24.3 deletions associated with 46, XY gonadal dysgenesis
and the ANKRD15 MR locus [17–19] and also appears to be
unrelated to the more common 9p minus syndrome (OMIM
158170).
There is some evidence that suggests some 9p subtelomeric
deletions may be normal variants. Techakittiroj and coworkers
reported a case of a patient with multiple congenital anomalies
and a 9p deletion [20]. Three asymptomatic individuals in this
family were also found to have a 9p subtelomeric deletion. It is
unknown if the 9p deletion in this family extends into the
DOCK8 gene region or if the symptomatic individual's deletion
is expanded compared to the asymptomatic family members.
The finding of a genomic interval common to two patients with
MR/DD in our study would suggest a likely role for a gene from
the critical region that may influence cognitive function.
Several putative genes are located within the MR critical
region. ESTs representing CBWD1 have been found in various
tissues, including fetal brain and especially in the hippocampus.
Another candidate is FOXD4, a member of the forkhead family
of transcription factors [21,22]. Many members of the forkhead
family are known to be key regulators of embryogenesis [23].
FOXD4 is widely expressed, most prominently in heart and
skeletal muscle [21]. Mutations in FOX genes have been
implicated in several human disorders, including the involve-
ment of the FOXP2 gene at 7q31 in a severe speech and
language disorder [24]. C9orf66 (UniGene Hs.190877) was
considered to be a less likely candidate since it has no similarity
to known proteins, and ESTs representing this putative gene
were isolated only from kidney, testis, and prostate cDNA
libraries.
One of two copies of DOCK8 was found to be physically
disrupted by the 9p subtelomeric deletion in one patient and by
the 9p24 translocation breakpoint in the second patient, which
suggests DOCK8 is a likely candidate for the MR features in
both patients. DOCK8 is expressed in both fetal and adult brain
and belongs to the dedicator of cytokinesis family of proteins.
These proteins are potential guanine nucleotide exchange
factors and activate some GTPases. DOCK8 has also been
200 B.L. Griggs et al. / Genomics 91 (2008) 195–202shown to interact with CDC42, a small GTPase of the Rho
subfamily [13]. Additionally, the authors [13] have shown
through immunofluorescence staining that DOCK8 is present at
the cell edges in areas undergoing lamellipodia formation. A
potential role for DOCK8 in the organization of filamentous
actin was suggested [13]. The lack of any measurable dif-
ferences in the actin cytoskeleton in patient CMS1485 with the
t(X;9) and in control fibroblast cells in our study could be
explained by the low level of expression of DOCK8 in the
fibroblast cells. It is also likely that the haploinsufficiency of
DOCK8 may not be sufficient to cause phenotypic changes
visible at the microscopic level.
The physiological and biological roles of the DOCK8
variants remain unknown. Recently, a homozygous deletion
including the DOCK8 locus at chromosome 9p24 was found in
a human lung cancer cell line [16]. Furthermore, localization of
DOCK8 protein in lamellipodia suggests that it might have a
role in cell migration, morphology, adhesion, and growth.
Further functional analysis of the DOCK8 isoforms is needed to
elucidate the biological and any pathogenic consequences of
DOCK8 mutations.
Several members of the DOCK family of proteins play roles
in neuronal development and function. A defect of the DOCK3
gene has been shown in a patient with an attention deficit
hyperactivity disorder-like phenotype [25]. Furthermore, a Rac
GTPase activator protein, DOCK7, has been shown to have a
role in axon formation and neuronal polarity [26]. Several genes
involved in Rho GTPase regulation and signaling have been
linked to mental retardation [27,28]. The interaction of DOCK8
with CDC42 suggests a possible mechanism whereby the
disruption of DOCK8 in our patients may result in their
impaired cognitive ability. Further analysis of DOCK8 in
patients with MR, as well as functional analysis in animal
models, should clarify the possible involvement of DOCK8 in
brain development and function.Materials and methods
Case report
Case 1 (CMS6482) is a 55-year-old white male with profound mental
retardation (IQ 2). He was born at term to a 19-year-old mother who had an
appendectomy at 4 months gestation. He was reported to weigh 14 pounds at
birth. He walked at age 11 months. At 1 year of age, he was found to have a
seizure disorder, unusual posturing, and no speech. As an adult, he developed
cataract with presbyopia and a cholesteatoma of the right ear. Physical
examination at age 47 revealed his height to be 166.5 cm, weight 61 kg, and
head circumference 55 cm (25th percentile). He had no speech. He had
significant balding, prominent supraorbital ridges, recessed eyes, midface
hypoplasia, and a square chin. His ears measured 7.7 cm bilaterally, with the left
having a more simple architecture. His fingertips were somewhat squared at the
tip with prominent pads. The distal phalanx of the left third finger was missing
from an accidental amputation. He walked into the exam room with a stooped
over posture. Normal laboratory studies included routine chromosome analysis
(450–650 band level), normal FMR1 gene expansion analysis, urine creatine,
urine organic acids, and plasma amino acids. FISH analysis with a subtelomeric
probe set (Vysis) revealed the 9p subtelomeric deletion (ish 9ptel (305J7x1)). No
other chromosomal abnormalities were detected elsewhere.
Case 2 (CMS1485, alias “ANLY”) has been previously described
[14,15,29,30]. This female patient was diagnosed with mental retardation andanhidrotic ectodermal dysplasia and had a de novo balanced translocation t(X;9)
(q13.1;p24). The patient was reported to have delayed speech and psychomotor
development. At age 7, she reportedly had education in a special school and
psychological assessment showed her functioning at the lower end of the
moderate MR range [29].
Cell culture
Peripheral blood lymphocytes of case 1 (CMS6482) were immortalized by
Epstein–Barr virus transformation to establish a lymphoblastoid cell line.
Fibroblast cell lines corresponding to patient CMS1485 (GM00705A) and a
control sample CMS11195 (GM03652F) were obtained from NIGMS human
genetic mutant cell repository, Coriell Institute for Medical Research (Camden,
NJ, USA). These cell lines were used for FISH experiments, RNA preparations,
and genomic DNA preparations using standard protocols.
Molecular cytogenetics
Genomic contigs, clones, markers, mapping, and sequence information were
obtained from the NCBI (http://www.ncbi.nlm.nih.gov/genome/guide/human)
databases.
BAC and PAC clones were obtained from commercial resources. DNAwas
isolated using Qiagen Mini-Prep columns and was labeled by incorporation of
digoxigenin-11–dUTP or biotin-16–dUTP (Boehringer Mannheim) by nick-
translation using DNA polymerase (Life Technologies). Labeled products were
combined with a 50× human Cot-1 DNA (Gibco BRL) and the chromosome-
specific labeled centromeric alphoid probe to a final concentration of 20 ng/μl in
Hybrisol VII. Probes were denatured at 76 °C for 10 min and preassociated at
37 °C for 15–20 min before hybridization.
For in situ hybridization, the metaphase chromosome spreads were obtained
from lymphoblastoid cells (CMS6482) or from fibroblast cells (CMS1485)
using conventional methods. Slides were incubated in 2× SSC at 37 °C for
30 min; serially dehydrated in 70, 80, and 95% ethanol at room temperature;
denatured in 70% formamide/2× SSC at 72 °C for 2 min; and then serially
dehydrated in 70, 80, and 95% ethanol. In situ hybridization and washing
procedures were performed as previously described [31,32]. Replication
banding was performed simultaneously with FISH. Commercially available
chromosome-specific labeled centromeric alphoid probes were used to identify
specific chromosomes. The labeled probes were visualized with rhodamine-
labeled anti-digoxigenin, and chromosomes were counterstained with DAPI.
Images were examined at 100× magnification under a Zeiss Axiophot
fluorescence microscope equipped with FITC, DAPI, and triple band-pass filter
sets. Digital images were captured by computer using Applied Imaging
Probevision software (Pittsburgh).
PFGE
High-molecular-weight DNA was isolated from patient fibroblasts in
agarose plugs by standard techniques. The plugs were digested with 80 U of
SalI for 16 h in appropriate endonuclease buffer. Digested fragments were
separated by electrophoresis on a 1% Seakem Gold agarose gel (Cambrex) at
6 V/cm for 22 h, at 12 °C in 0.5× TBE running buffer, using a 45-s pulse time on
a CHEF-DR III apparatus (Bio-Rad). After electrophoresis, samples were
transferred to a Hybond-N+ membrane (GE Healthcare) using an alkaline
downward transfer procedure. The filters were prehybridized at 65 °C for 2–3 h
in aqueous hybridization solution before adding the denatured probe.
A 938-bp cDNA amplicon from DOCK8 exon 41 to a portion of exon 47
was amplified using primers D8ex41.47 Forward, 5′-TCACATAGACTA-
GAGGCATTTTA-3′, and Reverse, 5′-GATCAGGGAGTGTACAGTCAGTC-
3′. The cDNA hybridization probe was labeled with [32P]dCTP using the
RadPrime DNA Labeling System (Invitrogen).
Quantitative real-time PCR
Genomic quantitative PCR was performed using iQ SYBR Green Supermix
(Bio-Rad) on an iCycler iQ real-time PCR detection system (Bio-
Rad). The experimental primer pair sequences were IVS13/F26IVS7 Forward,
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GGCCACCTCGCTGTAA-3′ (333-bp product); Exon18/D8ex18 Forward,
5′-TTGCTTGTTAGTAATCAGAAAAG-3 ′ , Reverse, 5′-GTCCC-
CACAAAGAACTAAAG-3′ (294-bp product); IVS23/D8IVS23a Forward,
5′-TCTCGCAGTGACATCCTC-3′, Reverse, 5′-ATTTGTGCTTTC-
TTCTCAGTG-3′ (151-bp product); Exon29/D8ex29 Forward, 5′-TGGGG-
AAATGTCATGTTTGA-3′, Reverse, 5′-CAGACACATGTGCACCAACA-3′
(214-bp product); Exon34/D8ex34 Forward, 5′-CTGAGCTAATTGTCAG-
GAAC-3′, Reverse, 5′-GAAGCTAGATGAGAATCTTACTC-3′ (272-bp
product). For the reference gene, a primer pair amplifying exon 16 of the
NEPH2 gene was used. The primer sequences were Forward, 5′-GGGCCAT-
CAGAGCTAAAGACC-3′ , and Reverse, 5′-CTTGGGGGAAGT-
GGAGGTTTA-3′ (210-bp product). The cycling conditions used an initial
5-min denaturation step at 95 °C followed by the two-step amplification cycles
at 95 °C for 10 s and 58 °C for 30 s repeated 40 times. Data were analyzed
using the iCycler iQ software to generate a standard curve for each gene and
calculate the fluorescence generated from the experimental primer pairs
relative to NEPH2 using the comparative Ct method.
Expression studies
Northern blots (Multiple Tissue Blots; BD Biosciences) containing poly(A)+
RNAs from different human brain sections (from individuals of ages 16–
75 years) were hybridized with a 457-bp DOCK8 cDNA probe spanning exons
22–25. The probe was labeled with [32P]dCTP using the RadPrime DNA
Labeling System (Invitrogen) and hybridization was performed following the
ExpressHyb (BD Biosciences) protocol. Filters were washed at high stringency
according to the manufacturer's recommendations.
Expression ofDOCK8 in fetal tissues was also measured by RT-PCR using a
human fetal multiple tissue cDNA panel (BD Bioscience) and the D8ex41.47
primer pair. Isoform-specific primers were used to examine expression of the
DOCK8 gene splice variants: variant 1, Dock8ex13-14 Forward, 5′-AAC-
GGCTCCTGTGTGTTCTT-3′, Reverse, 5′-TTGTAATGTTCCGGGCTGAT-3′
(155-bp product; annealing temperature 60 °C); variant 2, Dock8ex13a-14
Forward, 5′-GGGAAGACCATCTGCACCT-3′, Reverse, 5′-TCAGCCTCTGT-
GGGTAGACA-3′ (396-bp product; annealing temperature 60 °C); variant 3,
Dock8ex15-17 Forward, 5′-CAGCGGGCCTGAATTTCT-3′, Reverse, 5′-
TGGGAGACAGTAGGATCCAGTT-3′ (247-bp product; annealing tempera-
ture 60 °C);
Mutation screening
A patient cohort consisting of 145 female patients with MR was screened for
mutations in DOCK8. These patients previously tested negative for the MR-
causing FMR1 expansion. Four random normal individuals were also included
as controls. Primers flanking all DOCK8 exons were designed. Amplicons
corresponding to each exon were analyzed using IPS or DHPLC as previously
described [33,34]. Primer pair details are available on request.
Both strands of PCR products from patients with abnormally migrating
fragments and a normal control were amplified and sequenced using the
DYEnamic ET Dye Terminator Cycle Sequencing Kit (GE Healthcare) and an
automated MegaBACE 1000 DNA analysis system (GE Healthcare). Sequences
were analyzed using the DNASTAR program (Madison, WI, USA).
Fluorescence microscopy
The fibroblast cell lines CMS1485 and CMS11195 were seeded onto Nunc
Lab-Tek II CC2 chambered slides (Nalge Nunc International) at a density of
15,000 cells per well. Cells were grown overnight and then stained with Alexa
Fluor 488 phalloidin green and Sytox orange (Invitrogen). Briefly, cells were
washed two times with PBS and fixed with 4% paraformaldehyde for 5 min.
Cells were then permeabilized with 0.1% Triton X-100 in PBS for 5 min
followed by two washes with PBS. The cells were then incubated with a
quenching solution (1.02 g sodium acetate in 50 ml PBS) twice for 8 min each.
Cells were then incubated for 30 min in a blocking solution (2% horse serum,
0.4% BSA in PBS) with 200 μg/ml RNase A. Alexa Fluor 488 phalloidin green
diluted 1:200 in the blocking solution was applied to the cells for 1 h at roomtemperature. Cells were rinsed three times, 5 min each, with Block followed by a
final rinse in TS (10 mM Tris–HCl, pH 7.5, 15 mM NaCl). Sytox orange was
diluted to 2 μM in TS and added to the cells for 7 min at room temperature. The
cells were rinsed four times with PBS. Imaging was performed on an Axiovert
200 laser scanning microscope (Zeiss).Acknowledgments
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